End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2,020 KRW | -1.70% | +0.50% | -9.21% |
07/05 | Green Lifescience Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
06/03 | Green Lifescience Co., Ltd.'s Equity Buyback Plan Extended till September 6, 2024. | CI |
Business Summary
Number of employees: 70
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical
100.0
%
| 36,505 | 100.0 % | 22,369 | 100.0 % | -38.72% |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
South Korea
45.3
%
| 20,953 | 57.4 % | 10,132 | 45.3 % | -51.64% |
Europe
25.7
%
| 5,818 | 15.9 % | 5,749 | 25.7 % | -1.18% |
Others
22.6
%
| 7,448 | 20.4 % | 5,061 | 22.6 % | -32.05% |
Asia
6.4
%
| 2,286 | 6.3 % | 1,427 | 6.4 % | -37.58% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Gi-Seong Lee
CEO | Chief Executive Officer | 59 | - |
Joon-Hwa Yang
CEO | Chief Executive Officer | 53 | 24/22/24 |
Jae-Hang Park
AUD | Comptroller/Controller/Auditor | 51 | 01/16/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Joon-Hwa Yang
CEO | Chief Executive Officer | 53 | 24/22/24 |
Gi-Seong Lee
CEO | Chief Executive Officer | 59 | - |
Jeong-Ki Hong
BRD | Director/Board Member | 53 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 20,000,000 | 14,634,930 ( 73.17 %) | 687,530 ( 3.438 %) | 73.17 % |
Company contact information
Sector
Sales per region
1st Jan change | Capi. | |
---|---|---|
-9.21% | 29.32M | |
+19.64% | 43.3B | |
+21.25% | 22.22B | |
+18.92% | 15.43B | |
+20.14% | 14.48B | |
+53.19% | 12.72B | |
-0.05% | 6.79B | |
-11.11% | 6.71B | |
-8.87% | 5.73B | |
+14.68% | 5.5B |
- Stock Market
- Equities
- A114450 Stock
- Company Green Lifescience Co., Ltd.